Carlsmed (CARL) Price to Earnings (2025 - 2026)

Carlsmed's (CARL) quarterly Price to Earnings came in at 26.89 in Q2 2026, up 4.95% quarter-over-quarter from 28.29 in Q1 2026.

Analysis

Carlsmed (CARL) Price to Earnings (2025 - 2026) Analysis & Trends

Carlsmed (CARL) has reported Price to Earnings for 2 consecutive years, with 26.89 the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Price to Earnings changed N/A year-over-year to 26.89; the trailing twelve-month figure through Jun 2026 stood at 7.78 (changed N/A YoY), and the FY2025 full-year result was 5.81, changed N/A from the prior year.
Price to Earnings improved to 26.89 in Q2 2026 per CARL's latest filing, from 28.29 in the prior quarter.
Across five years, Price to Earnings topped out at 20.39 in Q4 2025 and bottomed at 33.11 in Q3 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn
10	Carlsmed	424.72 Mn	311.42 Mn	14.54 Mn

Historic Data

Download Data